Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.
other
Where this comes from
- Record sourced from PubMed, PMID 27978570.
- Also identified by DOI 10.1001/jamaoncol.2016.4983 and PMC identifier 5824236.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study compares reports from 2 next-generation sequencing tests to determine the level of concordance between platforms.
Medical subject headings
- High-Throughput Nucleotide Sequencing
- Neoplasms
- Sequence Analysis, DNA